Our singular focus is improving patient outcomes. Research is fundamental to making that a reality.
Our Vision
The Lustgarten Foundation envisions a world in which there is a cure for pancreatic cancer and patients can enjoy a good quality of life. We will achieve this vision by:
- Continuing to be the largest private funder of pancreatic cancer research in the world
- Striving for excellence
- Emphasizing compassion
- Having a commitment to serve
- Having integrity to our mission, to those we serve and to ourselves
Our Promise
As the nation’s largest private funder of pancreatic cancer research, we aren’t simply another voice in the dialogue calling for earlier detection and better therapies for pancreatic cancer, we started the conversation. Our responsibility is profound. We shine a spotlight on pancreatic cancer and do everything possible to improve the diagnosis and treatment of the disease. And we do this by funding leading-edge research.
Our Ongoing Commitment
We continue to make large-scale commitments to leading pancreatic cancer researchers by funding high-risk, high-reward studies stretching the boundaries of science. Looking ahead, our research program centers on areas with the greatest impact for patients.
- Earlier Detection
Goal: Develop and deliver tools enabling early diagnosis of pancreatic cancer; develop and optimize biomarkers enabling early detection in the general population; develop approaches for risk assessment and management of high-risk groups - Drug Development
Goal: Accelerate the development of therapies; identify novel drug targets based on understanding of the biology of pancreatic cancer initiation and progression; accelerate preclinical and clinical testing of novel drugs and combinations in pancreatic cancer - Personalized Medicine
Goal: Implement a personalized medicine program; better characterize and understand the heterogeneity of pancreatic cancer; develop tools to guide treatment decisions matching the right treatment to the right patient at the right time
We are unwavering in our commitment to changing patients’ lives, creating a larger community of survivors and giving patients hope. We believe it’s not a matter of if we are going to conquer this disease, it’s a matter of when.
